These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 6631699)

  • 1. Noninvasive assessments of the percutaneous absorption of methyl nicotinate in humans.
    Guy RH; Wester RC; Tur E; Maibach HI
    J Pharm Sci; 1983 Sep; 72(9):1077-9. PubMed ID: 6631699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Noninvasive assessment of local nicotinate pharmacodynamics by photoplethysmography.
    Tur E; Guy RH; Tur M; Maibach HI
    J Invest Dermatol; 1983 Jun; 80(6):499-503. PubMed ID: 6854050
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between percutaneous penetration of methyl nicotinate and sensitive skin, using laser Doppler imaging.
    Issachar N; Gall Y; Borrel MT; Poelman MC
    Contact Dermatitis; 1998 Oct; 39(4):182-6. PubMed ID: 9817223
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacodynamic measurements of methyl nicotinate percutaneous absorption: the effect of aging on microcirculation.
    Roskos KV; Bircher AJ; Maibach HI; Guy RH
    Br J Dermatol; 1990 Feb; 122(2):165-71. PubMed ID: 2317445
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacodynamic measurement of percutaneous penetration enhancement in vivo.
    Ryatt KS; Stevenson JM; Maibach HI; Guy RH
    J Pharm Sci; 1986 Apr; 75(4):374-7. PubMed ID: 2941564
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous responses to topical methyl nicotinate in human forearm and vulvar skin.
    Elsner P; Maibach HI
    J Dermatol Sci; 1991 Sep; 2(5):341-5. PubMed ID: 1742244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of ultrasound on the percutaneous absorption of nicotinate esters.
    Benson HA; McElnay JC; Harland R; Hadgraft J
    Pharm Res; 1991 Feb; 8(2):204-9. PubMed ID: 2023868
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Permeation, metabolism and site of action concentration of nicotinic acid derivatives in human skin. Correlation with topical pharmacological effect.
    Müller B; Kasper M; Surber C; Imanidis G
    Eur J Pharm Sci; 2003 Oct; 20(2):181-95. PubMed ID: 14550884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The rate of absorption and duration of action of four different solutions of methyl nicotinate.
    Fountain RB; Baker BS; Hadgraft JW; Sarkany I
    Br J Dermatol; 1969 Mar; 81(3):202-6. PubMed ID: 5775069
    [No Abstract]   [Full Text] [Related]  

  • 10. Time of erythema onset after application of methyl nicotinate ointments as response parameter: influence of penetration kinetics and enhancing agents.
    Remane Y; Leopold CS
    Skin Pharmacol Physiol; 2006; 19(6):303-10. PubMed ID: 16931897
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microdialysis technique as a method to study the percutaneous penetration of methyl nicotinate through excised human skin, reconstructed epidermis, and human skin in vivo.
    Boelsma E; Anderson C; Karlsson AM; Ponec M
    Pharm Res; 2000 Feb; 17(2):141-7. PubMed ID: 10751027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacodynamic measurements of methyl nicotinate percutaneous absorption.
    Guy RH; Tur E; Bugatto B; Gaebel C; Sheiner LB; Maibach HI
    Pharm Res; 1984 Mar; 1(2):76-81. PubMed ID: 24277216
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prostaglandins and nicotinate-provoked increase in cutaneous blood flow.
    Wilkin JK; Fortner G; Reinhardt LA; Flowers OV; Kilpatrick SJ; Streeter WC
    Clin Pharmacol Ther; 1985 Sep; 38(3):273-7. PubMed ID: 4028621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are there age and racial differences to methyl nicotinate-induced vasodilatation in human skin?
    Guy RH; Tur E; Bjerke S; Maibach HI
    J Am Acad Dermatol; 1985 Jun; 12(6):1001-6. PubMed ID: 3159763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Kinetics of blood flow after topical application of benzyl nicotinate on different anatomic sites.
    Jacobi U; Kaiser M; Sterry W; Lademann J
    Arch Dermatol Res; 2006 Nov; 298(6):291-300. PubMed ID: 16967307
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Percutaneous absorption: in vivo experiments.
    Albery WJ; Hadgraft J
    J Pharm Pharmacol; 1979 Mar; 31(3):140-7. PubMed ID: 34686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of charge and lipid concentration on in-vivo percutaneous absorption of methyl nicotinate from liposomal vesicles.
    Puglia C; Esposito E; Menegatti E; Nastruzzi C; Rizza L; Cortesi R; Bonina F
    J Pharm Pharmacol; 2005 Sep; 57(9):1169-76. PubMed ID: 16105237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of glycerol on the percutaneous absorption of methyl nicotinate.
    Hadgraft J; Hadgraft JW; Sarkany I
    Br J Dermatol; 1972 Jul; 87(1):30-6. PubMed ID: 5043196
    [No Abstract]   [Full Text] [Related]  

  • 19. The microvascular response in the skin to topical application of methyl nicotinate: Effect of concentration and variation between skin sites.
    Elawa S; Mirdell R; Tesselaar E; Farnebo S
    Microvasc Res; 2019 Jul; 124():54-60. PubMed ID: 30877017
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phonophoresis of methyl nicotinate: a preliminary study to elucidate the mechanism of action.
    McElnay JC; Benson HA; Harland R; Hadgraft J
    Pharm Res; 1993 Dec; 10(12):1726-31. PubMed ID: 8302758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.